This announcement is a separate document:
达嘉维康：关于收购宁夏德立信医药有限责任公司51%股权的公告
Dajia Weikang: Announcement on the acquisition of 51% of Ningxia Delixin Pharmaceutical Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.